Actualités Colloques | L'Institut Servier

18 May 2020

Interview with Doctor Gilles Boschetti

Gilles Boschetti, gastroenterologist at the Lyon’s CHU, monitors patients with chronic inflammatory bowel disease. As part of his study, he is interested in the possibility of defining and studying immune profiles. The objective: to offer patients the most personalized and active treatment as soon as they are diagnosed.

Read >

6 May 2020

Pollution believed to be a risk factor for autism spectrum disorders

According to American researchers, exposure to atmospheric pollution could increase the risk of ASD. A fetus has a three times higher chance of being born with autism if the moth-er was exposed to traffic pollution during the pregnancy.

Read >

29 April 2020

E. coli bacteria associated with Crohn’s disease develop antibiotic tolerance

Researchers have observed that Escherichia Coli bacteria found in Crohn’s disease trigger responses when faced with stress as a survivalmechanism. They multiply massively and colonize bowel cells before replicating in the macrophages thus cre-ating recurrent infections.

Read >

21 April 2020

France initiates a world first in the field of cardiology, with a non-invasive ultrasound therapy for calcified aortic stenosis (CAS)

Prof. Messas and his team have achieved a world first in the field of cardiology by treating 10 patients with calcified aortic stenosis using non-invasive, high-intensity ultrasound therapy. The results are encouraging and the researchers hope to develop the study in a larger sample of patients.

Read >

15 April 2020

Chronic diseases: Four out of 10 patients consider that they cannot cope with the burden of their treatment

A scientific study has revealed that almost 40% of patients with chronic conditions con-sider the “burden of treatment” to be unsustainable in terms of the energy, time and money invested.

Read >

8 April 2020

Everyday life of cancer patients with chemotherapy-induced nausea and vomiting

For cancer patients on chemotherapy, life can be a constant battle, with often daily nausea. Various studies have described individual risk factors for the de-velopment of such nausea, the aim being to more effectively prevent it.

Read >

25 March 2020

Multiple sclerosis: a study confirms the involvement of the gut in its development

According to German scientists, the gut may play a role in the development of multiple sclerosis. Cellular phenomena responsible for MS may have been identified in the intes-tines.

Read >

18 March 2020

Interview with Professor Marc Ychou, Digestive Oncologist – General Director of the Montpellier Cancer Institute

Professor Marc Ychou presents us with all the interest and ways of progress in the use of the circulating tumor DNA technique in order to better monitor patients treated in particular for colorectal or rectal cancers.

Read >

11 March 2020

Diabetes: a glucose-regulating protein identified

Researchers at the University of Geneva (UNIGE) hope that the S100A9 protein, or Cal-granulin B, may contribute to the development of a new-generation anti-diabetic drug.

Read >

4 March 2020

Interview with Dr Pierre Combe Oncologist specializing in gynecology

Doctor Pierre Combe tells us about future developments in terms of association and multiple therapeutic synergies regarding a more detailed distinction among the plurality of ovarian cancers.

Read >

News Colloquia

Interview with Doctor Gilles Boschetti

Pollution believed to be a risk factor for autism spectrum disorders

E. coli bacteria associated with Crohn’s disease develop antibiotic tolerance

France initiates a world first in the field of cardiology, with a non-invasive ultrasound therapy for calcified aortic stenosis (CAS)

Chronic diseases: Four out of 10 patients consider that they cannot cope with the burden of their treatment

Everyday life of cancer patients with chemotherapy-induced nausea and vomiting

Multiple sclerosis: a study confirms the involvement of the gut in its development

Interview with Professor Marc Ychou, Digestive Oncologist – General Director of the Montpellier Cancer Institute

Diabetes: a glucose-regulating protein identified

Interview with Dr Pierre Combe Oncologist specializing in gynecology

Pages